afdx 384 has been researched along with Body Weight in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellucci, A; Casamenti, F; Costagli, C; Pepeu, G; Scali, C; Schmidt, B | 1 |
| Buccafusco, JJ; Zhang, LC | 1 |
| Berlan, M; Galitzky, J; Merial, C; Montastruc, JL; Pelat, M; Senard, JM; Verwaerde, P | 1 |
3 other study(ies) available for afdx 384 and Body Weight
| Article | Year |
|---|---|
Effect of subchronic administration of metrifonate, rivastigmine and donepezil on brain acetylcholine in aged F344 rats.
Topics: Acetylcholine; Aging; Animals; Body Weight; Brain; Carbamates; Cerebral Cortex; Cholinesterase Inhibitors; Cholinesterases; Donepezil; Drug Administration Schedule; Hippocampus; Indans; Male; Muscarinic Antagonists; Phenylcarbamates; Piperidines; Pirenzepine; Rats; Rats, Inbred F344; Rivastigmine; Trichlorfon | 2002 |
Prevention of morphine-induced muscarinic (M2) receptor adaptation suppresses the expression of withdrawal symptoms.
Topics: Animals; Behavior, Animal; Blood Pressure; Body Weight; Disease Models, Animal; Infusions, Intravenous; Injections, Subcutaneous; Isoflurophate; Male; Morphine; Morphine Dependence; Naloxone; Pirenzepine; Rats; Rats, Wistar; Receptor, Muscarinic M2; Receptors, Muscarinic; Substance Withdrawal Syndrome; Vasomotor System | 1998 |
Impaired atrial M(2)-cholinoceptor function in obesity-related hypertension.
Topics: Adenylyl Cyclases; Animals; Blood Pressure; Body Weight; Dogs; Dose-Response Relationship, Drug; Heart Atria; Hypertension; Male; N-Methylscopolamine; Obesity; Pirenzepine; Receptor, Muscarinic M2; Receptors, Muscarinic | 1999 |